Denopol, Felisicima L.

HRN: 28-88-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
CEFTRIAXONE 1G (VIAL)
04/20/2026
04/26/2026
IV
2g
Q24
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: